Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer

In recent years, percutaneous radiofrequency ablation (RFA) has been developed as a new tool in the treatment of non-small-cell lung cancer (NSCLC) in non-surgical patients. There is growing evidence that RFA-mediated necrosis can modulate host immune responses. Here we analysed serum inflammatory f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Exp Immunol
Main Authors: Schneider, T, Sevko, A, Heussel, C P, Umansky, L, Beckhove, P, Dienemann, H, Safi, S, Utikal, J, Hoffmann, H, Umansky, V
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2015
Assuntos:
Translation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4449775/
https://ncbi.nlm.nih.gov/pubmed/25644608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.12596
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados